Harnessing apoptosis for improved anticancer gene therapy

DJ Waxman, PS Schwartz - Cancer research, 2003 - AACR
Advances in our understanding of the mechanisms by which tumor cells detect drug-induced
DNA damage leading to apoptotic death have aided in the design of novel, potentially more …

Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells

BT Kawasaki, T Mistree, EM Hurt, M Kalathur… - Biochemical and …, 2007 - Elsevier
Tumor immunology fundamentals suggest immunological surveillance has the ability to
recognize malignant cells and kill them before a tumor develops. However, cancer cells …

Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing

M Adachi, J Sampath, L Lan, D Sun, P Hargrove… - Journal of biological …, 2002 - ASBMB
The multidrug resistance protein MRP4, a member of the ATP-binding cassette superfamily,
confers resistance to purine-based antiretroviral agents. However, the antiviral agent …

Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme

JL Eller, SL Longo, DJ Hicklin, GW Canute - Neurosurgery, 2002 - journals.lww.com
OBJECTIVE: Overexpression of epidermal growth factor receptor (EGFR) in glioblastoma
multiforme (GBM) secondary to EGFR gene amplification is associated with a more …

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas

E Galanis, A Bateman, K Johnson, RM Diaz… - Human gene …, 2001 - liebertpub.com
Malignant gliomas are the most common primary brain tumors in adults and, with few
exceptions, have a dismal prognosis despite the therapeutic use of surgery, radiation …

Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene

T Asklund, IB Appelskog, O Ammerpohl… - Experimental cell …, 2003 - Elsevier
The ability of herpes simplex virus type 1 thymidine kinase (HSV-tk)-expressing cells
incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring HSV-tk-negative …

Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer

P Rochaix, N Delesque, JP Esteve… - Human Gene …, 1999 - liebertpub.com
Human pancreatic adenocarcinomas lose the ability to express sst2, the somatostatin
receptor, which mediates the antiproliferative effect of somatostatin. Reintroducing sst2 into …

Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human …

LZ Rubsam, PD Boucher, PJ Murphy, M KuKuruga… - Cancer research, 1999 - AACR
The ability of herpes simplex virus type 1 thymidine kinase (HSV-TK)-expressing cells
incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring HSV-TK-negative …

Gene transfer technologies for malignant gliomas

A Weyerbrock, EH Oldfield - Current opinion in oncology, 1999 - journals.lww.com
Although early clinical gene therapy trials for recurrent central nervous system neoplasms
showed the proof-of-principle, they did not fulfill the high expectations suggested by the …

Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

T Todo, SD Rabkin, RL Martuza - Cancer gene therapy, 2000 - nature.com
G207 is a multimutated, conditionally replicating herpes simplex virus type 1 (HSV-1) that
retains an intact viral thymidine kinase (HSV-tk) gene. The virus exhibits oncolytic activity in …